Time to competency must be reduced to get to market faster, says Virtuosi
Talent shortages and training issues were identified at Advanced Therapies 2022 as one of the challenges restricting ATMPs pathway to commercialization.  The difficulty to recruit highly-skilled individuals in the advanced therapy space has been heavily documented, and companies such as Lonz ...
Every single step of the vaccine process needs shortening says CEPI, which is developing a strategy to produce safe and effective vaccines agains ...- Bavarian Nordic will supply its smallpox vaccine Imvanex to at least two countries as cases of monkeypox surge in Europe and elsewhere.
The surg ...
- Eli Lilly is investing $2.1 billion to build two manufacturing facilities in Indiana to expand its services for active ingredients and therapeuti ...
- Hanmi Fine Chemical says the COVID-19 pandemic has increased the demand for RNA raw materials, causing it to launch CDMO services in relevant fie ...
Recent Tweets
-
RT @Dan5tanton: Two co-founders of Taiwanese firm JHL Biotech were sentenced last month for plotting to steal trade secrets from Ge… https://t.co/0iclK4yS7h
2 months ago
-
RT @frankvinluan: Shutdown comes 8 months after FDA sent a warning letter about a #microbiome metabolic therapy the #biotech was test… https://t.co/FgtTS54Yj0
2 months ago
-
RT @Dan5tanton: A win for CDMO Catalent as it further strengthens its global network, but potentially a loss to the UK taxpayer, wh… https://t.co/Ex9CNdbcf0
2 months ago
-
RT @Dan5tanton: The US Department of Health and Human Services #HHS has terminated a long-term #CDMO partnership with Emergent BioS… https://t.co/bAbKWb3uqQ
7 months ago
